GLP-1s raise new questions about preserving muscle with age

677. How to maintain muscle and hair as you age (and if you're on a GLP)

Reduced appetite, aggressive dieting, aging, and inactivity can all make muscle preservation harder, especially when exercise or adequate food intake is limited.

3 key takeaways
  1. 1GLP-1 medications and aggressive calorie restriction may reduce food intake enough to increase muscle-loss risk.
  2. 2High-leucine essential amino acids may help support muscle protein synthesis when appetite, calories, or exercise capacity decline.
  3. 3Creatine emerges as a broader tool for muscle maintenance, cellular energy, and brain health across aging and menopause.

Don't miss

Angelo connects NASA-related bed-rest research with the claim that supplemental essential amino acids may help prevent muscle loss when exercise is unavailable.

The brief

Angelo Keely and Amie Hornaman examine why GLP-1 medications, aggressive dieting, aging, and inactivity can converge on the same problem: inadequate support for muscle maintenance.

The central argument is that high-leucine essential amino acids may stimulate muscle protein synthesis when appetite and total calorie intake fall, while adequate whole-food protein remains the foundation.

The discussion extends beyond muscle to hair, skin, and other tissues, then turns to injury and bed rest, including NASA-related research on limiting muscle loss.

Protein targets become a practical question: amino acids may help when eating enough protein is difficult, but daily consistency matters more than occasional supplementation.

Creatine closes the discussion as a supplement for muscle, cellular energy, and potentially brain health, with particular relevance to women in perimenopause and menopause.

Weekly email

State of the Pod, every Monday

The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.

Listen to the full episode and explore every guest, topic, and moment on PodLume.